Haw Par Corporation Ltd
SGX:H02
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (16.6), the stock would be worth S$12.03 (30% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 23.8 | S$17.21 |
0%
|
| 3-Year Average | 16.6 | S$12.03 |
-30%
|
| 5-Year Average | 18.1 | S$13.08 |
-24%
|
| Industry Average | 21.2 | S$15.31 |
-11%
|
| Country Average | 5.9 | S$4.28 |
-75%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
|
Haw Par Corporation Ltd
SGX:H02
|
3.8B SGD | 23.8 | 14.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 16.9 | 42.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 8.8 | 26.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 6.3 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.3B GBP | 6.4 | 28 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 5.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF | 7.4 | 20.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 160.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 5.2 | 11.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 4.2 | 19.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 4.4 | 17.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 2.6 |
| Median | 5.9 |
| 70th Percentile | 10.3 |
| Max | 26 151.2 |
Other Multiples
Haw Par Corporation Ltd
Glance View
In the vibrant tapestry of Southeast Asian business, Haw Par Corporation Ltd. stands out as a unique blend of both tradition and innovation. Emerging from its roots as a family business founded in 1969, the company has grown into a diversified conglomerate, best known for its iconic Tiger Balm brand. Originally developed as a remedy inspired by ancient Chinese herbal medicine, Tiger Balm has evolved into a global household name. This tiny jar of relief epitomizes Haw Par’s ability to mesh cultural heritage with contemporary needs, capturing a significant share of the health and wellness market worldwide. The brand's entrenched position in the personal care sector, coupled with effective distribution networks and marketing strategies, ensures a steady stream of revenue flowing from markets across Asia, Europe, and the Americas. Beyond the allure of Tiger Balm, Haw Par's business model is strategically diversified. The company has smartly ventured into the fields of leisure and hospitality, healthcare investments, and property management. This diversification is a calculated play to mitigate risks associated with over-reliance on a single revenue stream. Their leisure segment features iconic attractions in Singapore, while their property holdings include high-value real estate that generates steady rental income. Additionally, Haw Par’s portfolio is anchored by substantial strategic investments in blue-chip stocks across the region, ensuring it partakes in the economic prosperity of Asia. Together, these well-curated ventures have created a robust financial ecosystem within the company, allowing it to maintain resilience in the face of economic fluctuations and to consistently drive shareholder value.